The period for Roche’s offer of $114.50 per share for U.S.-based Spark has been extended several times and was set to expire on Dec. 10.
MarketWatch.com - Top Stories, MarketWatch
Mon, 12/09/2019 - 2:08am
The period for Roche’s offer of $114.50 per share for U.S.-based Spark has been extended several times and was set to expire on Dec. 10.